The Meningitis and Sepsis Association is calling for people up to 25 years old to be protected with the meningococcal B vaccine

The Asociación Española contra la Meningitis y la Sepsis (AEMS), through its president Cristina Regojo, has issued a public call to protect adolescents and young adults up to the age of 25 using the meningococcal B vaccine.

The demand highlights the need for expanded immunization policies to cover populations within this specific age bracket against the risks associated with meningitis and sepsis.